ivWatch, an IV safety company, says its continuous IV site monitoring system is now available through the UK NHS Supply Chain. The announcement follows the company’s stated goal of giving NHS Trusts faster access to continuous monitoring designed to help reduce avoidable harm related to IV extravasation. The release frames the technology as an “innovative” approach to continuous site monitoring for patients receiving IV therapy, positioning it for use within NHS procurement channels via NHS Supply Chain.
Across the provided materials, there is only one outlet (PR Newswire) and the same story text is repeated. As presented, the information focuses on the rollout or availability pathway rather than on detailed clinical performance results, study data, pricing, or specific deployment timelines for individual Trusts. The release indicates that the product is intended to support safer IV treatment by monitoring IV sites continuously.
